update Updates

Risperdal Plaintiffs Request the Unsealing of Key Clinical Studies Data

Risperdal plaintiffs have asked a Pennsylvania judge to unseal clinical studies data citing its importance to the public interest according to court documents. The Rottenstein Law Group LLP which represents clients in Risperdal lawsuits notes that the documents detail potential risks associated with the antipsychotic drug. The request from… Read more

J&J Asks Judge to Keep Clinical Studies Sealed in Risperdal Lawsuits

Drug maker Johnson & Johnson has requested that a Pennsylvania state judge keep sealed documents pertaining to results of clinical studies involving antipsychotic medication Risperdal according to court documents. The Rottenstein Law Group LLP which represents clients in Risperdal lawsuits discusses the nature of the request and highlights recent news involving a multibillion… Read more

RLG Comments on $2 Billion Risperdal Settlement Report

Drug maker Johnson & Johnson has agreed to pay $2.2 billion in civil and criminal fines to settle claims it improperly marketed the antipsychotic medication Risperdal to children seniors and people with developmental disabilities. RLG which represents clients in Risperdal lawsuits notes that the federal government has reported that there are health… Read more

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.